APO Research
Talk to an analyst

APO RESEARCH · REPORT

Foot and Mouth Disease (FMD) Vaccines

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Selected research

Market Outlook & Growth Opportunities

Global Foot and Mouth Disease (FMD) Vaccines Market Outlook and Growth Opportunities 2026

21 December 2025213 pages

Choose your research edition.

Industry ResearchFoot and Mouth Disease (FMD) Vaccines Industry Research Report 2026145 pages · $2,950 USDIndustry Growth & TrendsGlobal Foot and Mouth Disease (FMD) Vaccines Industry Growth and Trends Forecast to 2032127 pages · $3,450 USDMarket StructureGlobal Foot and Mouth Disease (FMD) Vaccines Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Foot and Mouth Disease (FMD) Vaccines Market Outlook and Growth Opportunities 2026213 pages · $4,250 USDMarket Analysis & ForecastGlobal Foot and Mouth Disease (FMD) Vaccines Market Analysis and Forecast 2026-2032212 pages · $4,950 USD

Market perspective

Foot and Mouth Disease (FMD) vaccines are vaccines that provide active acquired immunity to Foot and Mouth Disease (FMD). Foot and Mouth Disease (FMD) is a highly contagious viral disease that primarily affects cloven-hooved livestock and wildlife like cattle, pigs, sheep and goats.

Global Foot and Mouth Disease (FMD) Vaccines key players include Jinyu Group, Indian Immunologicals, Tecon Group, CAHIC, etc. Global top four manufacturers hold a share nearly 60%.

Asia-Pacific is the largest market, with a share about 80%, followed by Central & South America, and Europe, both have a share over 15 percent.

Read the full market overview

In terms of product, Conventional Vaccines is the largest segment, with a share about 70%. And in terms of application, the largest application is Cattle, followed by Pig, Sheep and Goat , etc.

This report provides an overview of the global Foot and Mouth Disease (FMD) Vaccines market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Foot and Mouth Disease (FMD) Vaccines and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Foot and Mouth Disease (FMD) Vaccines sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Foot and Mouth Disease (FMD) Vaccines market size, projected growth trends, production technologies, key applications, and end-use industries.

Foot and Mouth Disease (FMD) Vaccines Segment by Company

Jinyu Group

Cavet Bio

Indian Immunologicals

Tecon Group

CAHIC

Shen Lian

Biogenesis Bagó

BIGVET Biotech

Boehringer Ingelheim

MSD Animal Health

CEVA

FGBI

Bayer HealthCare

Brilliant Bio Pharma

VECOL

Sanofi (Merial)

VETAL

BVI

LIMOR

ME VAC

Agrovet

Foot and Mouth Disease (FMD) Vaccines Segment by Type

Emergency Vaccines

Conventional Vaccines

Foot and Mouth Disease (FMD) Vaccines Segment by Application

Cattle

Pig

Sheep and Goat

Others

Foot and Mouth Disease (FMD) Vaccines Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Foot and Mouth Disease (FMD) Vaccines status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Foot and Mouth Disease (FMD) Vaccines market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Foot and Mouth Disease (FMD) Vaccines significant trends, drivers, influence factors in global and regions.

6. To analyze Foot and Mouth Disease (FMD) Vaccines competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Foot and Mouth Disease (FMD) Vaccines market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Foot and Mouth Disease (FMD) Vaccines and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Foot and Mouth Disease (FMD) Vaccines.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Foot and Mouth Disease (FMD) Vaccines market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Foot and Mouth Disease (FMD) Vaccines industry.

Chapter 3: Detailed analysis of Foot and Mouth Disease (FMD) Vaccines manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Foot and Mouth Disease (FMD) Vaccines in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Foot and Mouth Disease (FMD) Vaccines in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Foot and Mouth Disease (FMD) Vaccines Industry Trends Table 2. Foot and Mouth Disease (FMD) Vaccines Industry Drivers Table 3. Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges Table 4. Foot and Mouth Disease (FMD) Vaccines Industry Restraints Table 5. Global Foot and Mouth Disease (FMD) Vaccines Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Foot and Mouth Disease (FMD) Vaccines Revenue Share by Company (2021-2026) Table 7. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Company (M Doses) & (2021-2026) Table 8. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Company (2021-2026) Table 9. Global Foot and Mouth Disease (FMD) Vaccines Average Price (USD/K Doses) of Company (2021-2026) Table 10. Global Foot and Mouth Disease (FMD) Vaccines Company Ranking, (2024-2026) & (USD Million) Table 11. Global Foot and Mouth Disease (FMD) Vaccines Key Company Manufacturing Base & Headquarters Table 12. Global Foot and Mouth Disease (FMD) Vaccines Company, Product Type & Application Table 13. Global Foot and Mouth Disease (FMD) Vaccines Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Foot and Mouth Disease (FMD) Vaccines by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Emergency Vaccines Table 18. Significant Companies of Conventional Vaccines Table 19. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type 2021 VS 2025 VS 2032 (M Doses) Table 20. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2021-2026) & (M Doses) Table 21. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2027-2032) & (M Doses) Table 22. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Type (2021-2026) Table 23. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Type (2027-2032) Table 24. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 25. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2021-2026) & (US$ Million) Table 26. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2027-2032) & (US$ Million) Table 27. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type (2021-2026) Table 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type (2027-2032) Table 29. Significant Companies of Cattle Table 30. Significant Companies of Pig Table 31. Significant Companies of Sheep and Goat Table 32. Significant Companies of Others Table 33. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application 2021 VS 2025 VS 2032 (M Doses) Table 34. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2021-2026) & (M Doses) Table 35. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2027-2032) & (M Doses) Table 36. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Application (2021-2026) Table 37. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Application (2027-2032) Table 38. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application (2021-2026) Table 42. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application (2027-2032) Table 43. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Table 44. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2026) & (M Doses) Table 45. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2021-2026) Table 46. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2027-2032) & (M Doses) Table 47. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region (2027-2032) Table 48. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Region (2021-2026) Table 51. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Region (2027-2032) Table 53. Global Foot and Mouth Disease (FMD) Vaccines Market Average Price (USD/K Doses) by Region (2021-2026) Table 54. Global Foot and Mouth Disease (FMD) Vaccines Market Average Price (USD/K Doses) by Region (2027-2032) Table 55. Global Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2021 VS 2025 VS 2032 (M Doses) Table 56. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026) & (M Doses) Table 58. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2021-2026) Table 59. Global Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032) & (M Doses) Table 60. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Country (2027-2032) Table 61. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Market Share by Country (2021-2026) Table 63. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Market Share by Country (2027-2032) Table 65. Jinyu Group Company Information Table 66. Jinyu Group Business Overview Table 67. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 68. Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 69. Jinyu Group Recent Development Table 70. Cavet Bio Company Information Table 71. Cavet Bio Business Overview Table 72. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 73. Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 74. Cavet Bio Recent Development Table 75. Indian Immunologicals Company Information Table 76. Indian Immunologicals Business Overview Table 77. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 78. Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 79. Indian Immunologicals Recent Development Table 80. Tecon Group Company Information Table 81. Tecon Group Business Overview Table 82. Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 83. Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 84. Tecon Group Recent Development Table 85. CAHIC Company Information Table 86. CAHIC Business Overview Table 87. CAHIC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 88. CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 89. CAHIC Recent Development Table 90. Shen Lian Company Information Table 91. Shen Lian Business Overview Table 92. Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 93. Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 94. Shen Lian Recent Development Table 95. Biogenesis Bagó Company Information Table 96. Biogenesis Bagó Business Overview Table 97. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 98. Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 99. Biogenesis Bagó Recent Development Table 100. BIGVET Biotech Company Information Table 101. BIGVET Biotech Business Overview Table 102. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 103. BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 104. BIGVET Biotech Recent Development Table 105. Boehringer Ingelheim Company Information Table 106. Boehringer Ingelheim Business Overview Table 107. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 108. Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 109. Boehringer Ingelheim Recent Development Table 110. MSD Animal Health Company Information Table 111. MSD Animal Health Business Overview Table 112. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 113. MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 114. MSD Animal Health Recent Development Table 115. CEVA Company Information Table 116. CEVA Business Overview Table 117. CEVA Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 118. CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 119. CEVA Recent Development Table 120. FGBI Company Information Table 121. FGBI Business Overview Table 122. FGBI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 123. FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 124. FGBI Recent Development Table 125. Bayer HealthCare Company Information Table 126. Bayer HealthCare Business Overview Table 127. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 128. Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 129. Bayer HealthCare Recent Development Table 130. Brilliant Bio Pharma Company Information Table 131. Brilliant Bio Pharma Business Overview Table 132. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 133. Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 134. Brilliant Bio Pharma Recent Development Table 135. VECOL Company Information Table 136. VECOL Business Overview Table 137. VECOL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 138. VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 139. VECOL Recent Development Table 140. Sanofi (Merial) Company Information Table 141. Sanofi (Merial) Business Overview Table 142. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 143. Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 144. Sanofi (Merial) Recent Development Table 145. VETAL Company Information Table 146. VETAL Business Overview Table 147. VETAL Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 148. VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 149. VETAL Recent Development Table 150. BVI Company Information Table 151. BVI Business Overview Table 152. BVI Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 153. BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 154. BVI Recent Development Table 155. LIMOR Company Information Table 156. LIMOR Business Overview Table 157. LIMOR Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 158. LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 159. LIMOR Recent Development Table 160. ME VAC Company Information Table 161. ME VAC Business Overview Table 162. ME VAC Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 163. ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 164. ME VAC Recent Development Table 165. Agrovet Company Information Table 166. Agrovet Business Overview Table 167. Agrovet Foot and Mouth Disease (FMD) Vaccines Sales (M Doses), Value (US$ Million), Price (USD/K Doses) and Gross Margin (2021-2026) Table 168. Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio Table 169. Agrovet Recent Development Table 170. Key Raw Materials Table 171. Raw Materials Key Suppliers Table 172. Foot and Mouth Disease (FMD) Vaccines Distributors List Table 173. Foot and Mouth Disease (FMD) Vaccines Customers List Table 174. Research Programs/Design for This Report Table 175. Authors List of This Report Table 176. Secondary Sources Table 177. Primary Sources List of Figures Figure 1. Foot and Mouth Disease (FMD) Vaccines Product Image Figure 2. Global Foot and Mouth Disease (FMD) Vaccines Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 4. Global Foot and Mouth Disease (FMD) Vaccines Sales (2021-2032) & (M Doses) Figure 5. Global Foot and Mouth Disease (FMD) Vaccines Sales Average Price (USD/K Doses) & (2021-2032) Figure 6. Global Foot and Mouth Disease (FMD) Vaccines Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Emergency Vaccines Image Figure 10. Conventional Vaccines Image Figure 11. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2021 VS 2025 VS 2032) & (M Doses) Figure 12. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 13. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Type (2021-2032) Figure 14. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 15. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 16. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type (2021-2032) Figure 17. Cattle Image Figure 18. Pig Image Figure 19. Sheep and Goat Image Figure 20. Others Image Figure 21. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2021 VS 2025 VS 2032) & (M Doses) Figure 22. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Application (2021-2032) Figure 24. Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application (2021-2032) Figure 27. Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032 (M Doses) Figure 28. Global Foot and Mouth Disease (FMD) Vaccines Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 32. North America Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 38. South America Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Foot and Mouth Disease (FMD) Vaccines Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Foot and Mouth Disease (FMD) Vaccines Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Emergency Vaccines
  • Conventional Vaccines
Applications
  • Cattle
  • Pig
  • Sheep and Goat
  • Others
Companies covered
  • Jinyu Group
  • Cavet Bio
  • Indian Immunologicals
  • Tecon Group
  • CAHIC
  • Shen Lian
  • Biogenesis Bagó
  • BIGVET Biotech
  • Boehringer Ingelheim
  • MSD Animal Health
  • CEVA
  • FGBI
  • Bayer HealthCare
  • Brilliant Bio Pharma
  • VECOL
  • Sanofi (Merial)
  • VETAL
  • BVI
  • LIMOR
  • ME VAC
  • Agrovet

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  4. 1.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume (2021-2032)
  5. 1.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Foot and Mouth Disease (FMD) Vaccines Market Dynamics
  1. 2.1 Foot and Mouth Disease (FMD) Vaccines Industry Trends
  2. 2.2 Foot and Mouth Disease (FMD) Vaccines Industry Drivers
  3. 2.3 Foot and Mouth Disease (FMD) Vaccines Industry Opportunities and Challenges
  4. 2.4 Foot and Mouth Disease (FMD) Vaccines Industry Restraints
3 Foot and Mouth Disease (FMD) Vaccines Market by Company
  1. 3.1 Global Foot and Mouth Disease (FMD) Vaccines Company Revenue Ranking in 2025
  2. 3.2 Global Foot and Mouth Disease (FMD) Vaccines Revenue by Company (2021-2026)
  3. 3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Company (2021-2026)
  4. 3.4 Global Foot and Mouth Disease (FMD) Vaccines Average Price by Company (2021-2026)
  5. 3.5 Global Foot and Mouth Disease (FMD) Vaccines Company Ranking (2024-2026)
  6. 3.6 Global Foot and Mouth Disease (FMD) Vaccines Company Manufacturing Base and Headquarters
  7. 3.7 Global Foot and Mouth Disease (FMD) Vaccines Company Product Type and Application
  8. 3.8 Global Foot and Mouth Disease (FMD) Vaccines Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Foot and Mouth Disease (FMD) Vaccines Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Foot and Mouth Disease (FMD) Vaccines Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Foot and Mouth Disease (FMD) Vaccines Market by Type
  1. 4.1 Foot and Mouth Disease (FMD) Vaccines Type Introduction
  2. 4.1.1 Emergency Vaccines
  3. 4.1.2 Conventional Vaccines
  4. 4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type
  5. 4.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2021 VS 2025 VS 2032)
  6. 4.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Type (2021-2032)
  7. 4.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Type (2021-2032)
  8. 4.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type
  9. 4.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Type (2021-2032)
  11. 4.3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type (2021-2032)
5 Foot and Mouth Disease (FMD) Vaccines Market by Application
  1. 5.1 Foot and Mouth Disease (FMD) Vaccines Application Introduction
  2. 5.1.1 Cattle
  3. 5.1.2 Pig
  4. 5.1.3 Sheep and Goat
  5. 5.1.4 Others
  6. 5.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application
  7. 5.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume by Application (2021-2032)
  9. 5.2.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Volume Share by Application (2021-2032)
  10. 5.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application
  11. 5.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Application (2021-2032)
  13. 5.3.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application (2021-2032)
6 Foot and Mouth Disease (FMD) Vaccines Regional Sales and Value Analysis
  1. 6.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2021-2032)
  3. 6.2.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region: 2021-2026
  4. 6.2.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Region (2027-2032)
  5. 6.3 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2021-2032)
  7. 6.4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region: 2021-2026
  8. 6.4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Region (2027-2032)
  9. 6.5 Global Foot and Mouth Disease (FMD) Vaccines Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  12. 6.6.2 North America Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  15. 6.7.2 Europe Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  21. 6.9.2 South America Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Country, 2025 VS 2032
7 Foot and Mouth Disease (FMD) Vaccines Country-level Sales and Value Analysis
  1. 7.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2032)
  4. 7.3.1 Global Foot and Mouth Disease (FMD) Vaccines Sales by Country (2021-2026)
  5. 7.3.2 Global Foot and Mouth Disease (FMD) Vaccines Sales by Country (2027-2032)
  6. 7.4 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2021-2032)
  7. 7.4.1 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2021-2026)
  8. 7.4.2 Global Foot and Mouth Disease (FMD) Vaccines Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Foot and Mouth Disease (FMD) Vaccines Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Foot and Mouth Disease (FMD) Vaccines Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Jinyu Group
  2. 8.1.1 Jinyu Group Company Information
  3. 8.1.2 Jinyu Group Business Overview
  4. 8.1.3 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Jinyu Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  6. 8.1.5 Jinyu Group Recent Developments
  7. 8.2 Cavet Bio
  8. 8.2.1 Cavet Bio Company Information
  9. 8.2.2 Cavet Bio Business Overview
  10. 8.2.3 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Cavet Bio Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  12. 8.2.5 Cavet Bio Recent Developments
  13. 8.3 Indian Immunologicals
  14. 8.3.1 Indian Immunologicals Company Information
  15. 8.3.2 Indian Immunologicals Business Overview
  16. 8.3.3 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Indian Immunologicals Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  18. 8.3.5 Indian Immunologicals Recent Developments
  19. 8.4 Tecon Group
  20. 8.4.1 Tecon Group Company Information
  21. 8.4.2 Tecon Group Business Overview
  22. 8.4.3 Tecon Group Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Tecon Group Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  24. 8.4.5 Tecon Group Recent Developments
  25. 8.5 CAHIC
  26. 8.5.1 CAHIC Company Information
  27. 8.5.2 CAHIC Business Overview
  28. 8.5.3 CAHIC Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 CAHIC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  30. 8.5.5 CAHIC Recent Developments
  31. 8.6 Shen Lian
  32. 8.6.1 Shen Lian Company Information
  33. 8.6.2 Shen Lian Business Overview
  34. 8.6.3 Shen Lian Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Shen Lian Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  36. 8.6.5 Shen Lian Recent Developments
  37. 8.7 Biogenesis Bagó
  38. 8.7.1 Biogenesis Bagó Company Information
  39. 8.7.2 Biogenesis Bagó Business Overview
  40. 8.7.3 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Biogenesis Bagó Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  42. 8.7.5 Biogenesis Bagó Recent Developments
  43. 8.8 BIGVET Biotech
  44. 8.8.1 BIGVET Biotech Company Information
  45. 8.8.2 BIGVET Biotech Business Overview
  46. 8.8.3 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 BIGVET Biotech Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  48. 8.8.5 BIGVET Biotech Recent Developments
  49. 8.9 Boehringer Ingelheim
  50. 8.9.1 Boehringer Ingelheim Company Information
  51. 8.9.2 Boehringer Ingelheim Business Overview
  52. 8.9.3 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Boehringer Ingelheim Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  54. 8.9.5 Boehringer Ingelheim Recent Developments
  55. 8.10 MSD Animal Health
  56. 8.10.1 MSD Animal Health Company Information
  57. 8.10.2 MSD Animal Health Business Overview
  58. 8.10.3 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 MSD Animal Health Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  60. 8.10.5 MSD Animal Health Recent Developments
  61. 8.11 CEVA
  62. 8.11.1 CEVA Company Information
  63. 8.11.2 CEVA Business Overview
  64. 8.11.3 CEVA Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 CEVA Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  66. 8.11.5 CEVA Recent Developments
  67. 8.12 FGBI
  68. 8.12.1 FGBI Company Information
  69. 8.12.2 FGBI Business Overview
  70. 8.12.3 FGBI Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 FGBI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  72. 8.12.5 FGBI Recent Developments
  73. 8.13 Bayer HealthCare
  74. 8.13.1 Bayer HealthCare Company Information
  75. 8.13.2 Bayer HealthCare Business Overview
  76. 8.13.3 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bayer HealthCare Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  78. 8.13.5 Bayer HealthCare Recent Developments
  79. 8.14 Brilliant Bio Pharma
  80. 8.14.1 Brilliant Bio Pharma Company Information
  81. 8.14.2 Brilliant Bio Pharma Business Overview
  82. 8.14.3 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Brilliant Bio Pharma Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  84. 8.14.5 Brilliant Bio Pharma Recent Developments
  85. 8.15 VECOL
  86. 8.15.1 VECOL Company Information
  87. 8.15.2 VECOL Business Overview
  88. 8.15.3 VECOL Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 VECOL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  90. 8.15.5 VECOL Recent Developments
  91. 8.16 Sanofi (Merial)
  92. 8.16.1 Sanofi (Merial) Company Information
  93. 8.16.2 Sanofi (Merial) Business Overview
  94. 8.16.3 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  95. 8.16.4 Sanofi (Merial) Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  96. 8.16.5 Sanofi (Merial) Recent Developments
  97. 8.17 VETAL
  98. 8.17.1 VETAL Company Information
  99. 8.17.2 VETAL Business Overview
  100. 8.17.3 VETAL Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  101. 8.17.4 VETAL Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  102. 8.17.5 VETAL Recent Developments
  103. 8.18 BVI
  104. 8.18.1 BVI Company Information
  105. 8.18.2 BVI Business Overview
  106. 8.18.3 BVI Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  107. 8.18.4 BVI Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  108. 8.18.5 BVI Recent Developments
  109. 8.19 LIMOR
  110. 8.19.1 LIMOR Company Information
  111. 8.19.2 LIMOR Business Overview
  112. 8.19.3 LIMOR Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  113. 8.19.4 LIMOR Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  114. 8.19.5 LIMOR Recent Developments
  115. 8.20 ME VAC
  116. 8.20.1 ME VAC Company Information
  117. 8.20.2 ME VAC Business Overview
  118. 8.20.3 ME VAC Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  119. 8.20.4 ME VAC Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  120. 8.20.5 ME VAC Recent Developments
  121. 8.21 Agrovet
  122. 8.21.1 Agrovet Company Information
  123. 8.21.2 Agrovet Business Overview
  124. 8.21.3 Agrovet Foot and Mouth Disease (FMD) Vaccines Sales, Value and Gross Margin (2021-2026)
  125. 8.21.4 Agrovet Foot and Mouth Disease (FMD) Vaccines Product Portfolio
  126. 8.21.5 Agrovet Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Foot and Mouth Disease (FMD) Vaccines Value Chain Analysis
  2. 9.1.1 Foot and Mouth Disease (FMD) Vaccines Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Foot and Mouth Disease (FMD) Vaccines Sales Mode & Process
  6. 9.2 Foot and Mouth Disease (FMD) Vaccines Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Foot and Mouth Disease (FMD) Vaccines Distributors
  9. 9.2.3 Foot and Mouth Disease (FMD) Vaccines Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst